Paul Forsyth
banner
pharmacisthf.bsky.social
Paul Forsyth
@pharmacisthf.bsky.social
Pharmacist, FRPharmS (Consultant), Equal parts cardiology 🫀, philosophical pharmacy angst 💊💭🤯, and mid-40s life stuff 👧👧👧👩‍💼🐕‍🦺 #HeartFailure #PharmSky #CardioSky 🏴󠁧󠁢󠁳󠁣󠁴󠁿☘️

https://scholar.google.com/citations?user=yrHCleUAAAAJ&hl=en
Pinned
Senses of belonging & flourishing are vital in the success & fulfilment of a profession

Understanding why these may become inhibited could help increase wellbeing & retention of pharmacists

See our systematic review of the international literature

#PharmSky

www.sciencedirect.com/science/arti...
Reposted by Paul Forsyth
It seems PubMed has disappeared. This is the digital equivalent of burning a library.
March 2, 2025 at 8:17 AM
Reposted by Paul Forsyth
Senses of belonging & flourishing are vital in the success & fulfilment of a profession

Understanding why these may become inhibited could help increase wellbeing & retention of pharmacists

See our systematic review of the international literature

#PharmSky

www.sciencedirect.com/science/arti...
February 18, 2025 at 7:17 PM
Reposted by Paul Forsyth
Our systematic review of international literature addressing alienation/anomie in pharmacists - led by @pharmacisthf.bsky.social - is now online (open access for 50 days). www.sciencedirect.com/science/arti...
Alienation and/or anomie in pharmacists: A systematic review and narrative synthesis of the international literature
Flourishing and belonging are key concepts for the wellbeing of staff and the success of a profession. Alienation and anomie are distinct types of psy…
www.sciencedirect.com
February 19, 2025 at 8:45 AM
Senses of belonging & flourishing are vital in the success & fulfilment of a profession

Understanding why these may become inhibited could help increase wellbeing & retention of pharmacists

See our systematic review of the international literature

#PharmSky

www.sciencedirect.com/science/arti...
February 18, 2025 at 7:17 PM
Achieving ‘meaning’ in work is complex, involving trying to attain objective endpoints through different subjective duties
podcasts.apple.com/gb/podcast/phi…

Pharmacists mainly agree on the endpoint (patient health) but do we agree on the subjective professional duties & does this matter#PharmSkyky
February 14, 2025 at 3:06 PM
Fascinating report from the US Surgeon General (“My Parting Prescription for America”), discussing the links between health, community, and fulfillment.

Thanks for flagging it @barrymaguire.bsky.social

www.hhs.gov/sites/defaul...
January 13, 2025 at 11:33 AM
EMPRESS-MI: ‘In patients with left ventricular systolic dysfunction after an acute MI receiving contemporary standard of care, treatment with empagliflozin had no effect on cardiac volumes or LVEF compared with placebo’

onlinelibrary.wiley.com/doi/10.1002/...
Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction (EMPRESS‐MI)
Aims Patients with a reduced left ventricular ejection fraction (LVEF) following an acute myocardial infarction (MI) are considered to be at risk of progressive adverse cardiac remodelling which can.....
onlinelibrary.wiley.com
December 18, 2024 at 6:30 PM
This is a great opportunity for pharmacists (or pharmacy technicians) to publish their innovative service models 👇

escpweb.org/escp-best-pr...
ESCP Best Practice Paper Call - ESCP
ESCP wants your best practice! Deadline for abstract submissions 31 January 2025. We want your best practice! The European Society of Clinical Pharmacy (ESCP) and the International Journal of Clinical...
escpweb.org
December 4, 2024 at 8:37 PM
Fascinating paper on factors that impact on registration exam passes for UK pharmacists 👀

academic.oup.com/ijpp/advance...
December 4, 2024 at 8:09 PM
Reposted by Paul Forsyth
1/Medications cause or contribute to
- 8-12% of ED visits
- 37% result in hospitalization

Using ED stats for BC, this is ~279,000 ED visits in BC each year:
- 103,000 hospital admission/year
- Cost upwards of $2 billion/year
The burden on pts & systems is immense!
#medsky #pharmsky #EMsky #GPsky
November 30, 2024 at 7:38 PM
Reposted by Paul Forsyth
RPS Fellows List is officially OUT!
819 now 🤩
Congratulations to all Fellow pharmacists who have been successfully nominated.
Happy Friday everyone!
If there’s a friend on the list who you know but haven’t spoken to in a while. Message them & share the joy! #PharmSky
www.rpharms.com/about-us/new...
November 29, 2024 at 11:06 AM
Reposted by Paul Forsyth
My UK chief pharmaceutical officers colleagues & I have provided advice to help pharmacy professionals wanting to take part in the debate on assisted dying. This follows similar advice recently issued to doctors and nurses: www.gov.uk/government/p...
Assisted dying bill debate: advice to pharmacy professionals
The UK chief pharmaceutical officers have given advice to help pharmacists and pharmacy technicians wanting to take part in the assisted dying debate.
www.gov.uk
November 22, 2024 at 10:50 PM
Reposted by Paul Forsyth
Reposted by Paul Forsyth
Time to end the disparity of HF care across the UK. The unfortunate thing is that there are individuals willing to drive that change, but restricted by local politics.

www.bbc.co.uk/news/article...
Twins with heart failure call for end to healthcare 'lottery'
Nicole and Farrah live just 32 miles from each other in Northern Ireland, but are in different health trusts.
www.bbc.co.uk
November 17, 2024 at 5:21 PM
Reposted by Paul Forsyth
WOW! So many ☀️ profiles!
Thank you for following me. I’ll do my best to help connect you.
Here’s my starter pack go.bsky.app/PzopiA9
My tips:
🦋 Use starter packs - there’s lots
🦋 Use #Pharmsky in your posts & add to your bio
🦋 Post lots by replies & share content
🦋 Like AND REPOST
🦋 Be kind
November 16, 2024 at 9:59 PM
VANISH2: Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia

#AHA2024

www.nejm.org/doi/full/10....
Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia | NEJM
Patients with ventricular tachycardia and ischemic cardiomyopathy are at high risk for adverse outcomes. Catheter ablation is commonly used when antiarrhythmic drugs do not suppress ventricular tac...
www.nejm.org
November 17, 2024 at 4:29 PM
CLEAR trial (Part 2): Should we routinely use Colchicine after acute myocardial infarction?

Also no!

#AHA2024

www.nejm.org/doi/full/10....
Colchicine in Acute Myocardial Infarction | NEJM
Inflammation is associated with adverse cardiovascular events. Data from recent trials suggest that colchicine reduces the risk of cardiovascular events. In this multicenter trial with a 2-by-2 fac...
www.nejm.org
November 17, 2024 at 4:25 PM
CLEAR trial: Should we routinely use Spironolactone after Acute Myocardial Infarction?

No!

#AHA2024

www.nejm.org/doi/full/10....
Routine Spironolactone in Acute Myocardial Infarction | NEJM
Mineralocorticoid receptor antagonists have been shown to reduce mortality in patients after myocardial infarction with congestive heart failure. Whether routine use of spironolactone is beneficial...
www.nejm.org
November 17, 2024 at 4:19 PM
Reposted by Paul Forsyth
Before the porridge moralists jump in, pls note, that the report found poorer households would have to *double* their food spend to be able to eat a healthy diet.

Poverty sickens society. Raise benefits & minimum wage, for cost effective benefits to society.

www.theguardian.com/politics/202...
UK’s unhealthy food habits cost £268bn a year, report finds
Exclusive: Food, Farming and Countryside Commission added up cost to NHS and economy of diet-linked disease
www.theguardian.com
November 16, 2024 at 9:36 AM
BPROAD trial: “Among patients with T2 diabetes, the incidence of major CVD events was significantly lower with intensive treatment targeting a systolic blood pressure of <120 mm Hg than with standard treatment targeting a systolic blood pressure of <140 mm Hg”

www.nejm.org/doi/full/10....
Intensive Blood-Pressure Control in Patients with Type 2 Diabetes | NEJM
Effective targets for systolic blood-pressure control in patients with type 2 diabetes are unclear. We enrolled patients 50 years of age or older with type 2 diabetes, elevated systolic blood press...
www.nejm.org
November 16, 2024 at 3:41 PM
SUMMIT trial: “Treatment with tirzepatide led to a lower risk of a composite of death from cardiovascular causes or worsening heart failure than placebo and improved health status in patients with heart failure with preserved ejection fraction and obesity”
www.nejm.org/doi/full/10....
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity | NEJM
Obesity increases the risk of heart failure with preserved ejection fraction. Tirzepatide, a long-acting agonist of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor...
www.nejm.org
November 16, 2024 at 3:33 PM
Reposted by Paul Forsyth
An excellent episode from an excellent podcast series
THMs:

In heart failure with congestive AKI diuretics aren’t a nephrotic in to be stopped
Diuretics don’t flog kidneys - they turn off highly energy consuming ion channels so help the kidneys!
podcasts.apple.com/gb/podcast/c...
Heart Failure: a HF-rEFerence Guide (4 Nov 2024)
Podcast Episode · Clinical Conversations · 04/11/2024 · 51m
podcasts.apple.com
November 10, 2024 at 2:13 PM
Amazing to see an almost 20% weight reduction with three years of tirzepatide treatment

It would be good though to see government tackle the obesogenic environments in society, so less people required such treatments

www.nejm.org/doi/full/10....
Tirzepatide for Obesity Treatment and Diabetes Prevention | NEJM
Obesity is chronic disease and causal precursor to myriad other conditions, including type 2 diabetes. In an earlier analysis of the SURMOUNT-1 trial, tirzepatide was shown to provide substantial a...
www.nejm.org
November 15, 2024 at 7:12 PM